Artificial-intelligence startup PathAI on Monday said it acquired Poplar, the management service arm of pathology laboratory Poplar Healthcare. PathAI, a Boston-based startup that develops AI ...

PathAI has launched the PathAssist Derm AI tool, which is designed for orienting, detecting, and measuring skin lesions. This new offering, now available on the AISight image management system ...

BOSTON and MEMPHIS, Tenn., July 26, 2021 /PRNewswire/ -- PathAI, a global provider of artificial intelligence-powered technology for pathology, announced their acquisition of Poplar, the ...

PathAI Biopharma chief business officer and president Matt Grow said: “We are thrilled to partner with Clario to provide a cutting-edge solution for IBD [inflammatory bowel disease] clinical trials.

PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, today announced that Nick Anderson, Ph.D., has joined as Vice ...

Commerce Secretary Gina Raimondo's husband has deepened his financial investment in the artificial intelligence company PathAI, a business that has raised eyebrows as it is backed by a company ...

BOSTON--(BUSINESS WIRE)--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that their recent research will be presented at the 2022 AACR ...

BOSTON, April 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of IBD ExploreTM and AIM-HI UCTM at ...

BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U ...

As part of the transaction, Quest bought out PathAI’s diagnostics lab in Memphis and rebranded the facility as AmeriPath. According to Quest, the site will act as an AI, digital R&D and ...